Anavex Life Sciences Corp (AVXL)

[Amatuer17]

See this ALZ product and trials - co completed P1, double blind placebo controlled P2b for 399 patients with very good results and completed enrollment of 800 patients for P3 study for ALZ - it is a non-plaque approach. It seems way better than AVXL

http://vtvtherapeutics.com/pipeline/azeliragon

So why AVXL is so special and it has done that will force FDA to allow them to exclude P2b - dose optimization and large P3 study?

What you have is 32 patient - 7 dropped - non-conclusive study.